March Group invests in a globally diversified portfolio of assets. Our strategic holdings include healthcare as well as private equity and, increasingly, impact investing.

March Group has been based in Bermuda since its formation, as Bermuda provides both stability and easy access to the U.S. and Europe, thus anchoring a global investment perspective.

After the sale of the family’s business – Boehringer Mannheim – in 1998, we diversified our investment portfolio, while retaining a strong presence in healthcare and private equity.

Today, we work with leading investment managers and strategic advisors around the world whose insights inform our investment approaches.

March Group’s approach has always been guided by a strong sense of responsibility and purpose. We are currently working to make our entire investment portfolio sustainable by eliminating any investments from our portfolio that may be harmful under environmental, social or governance criteria (ESG).

We are seeking to engage in a strategy of impact investing, which will direct our resources towards investments that deliver a positive social or environmental outcome, as well as being financially sound. This aligns with our sense of corporate social responsibility.

About

March Group is a closely held group of private investment companies. Until 1988, March Group's primary asset was a strategic stake in Boehringer Mannheim, a global healthcare and pharmaceutical concern.

Our History

The origins of March Group go back to the 19th Century, when Boehringer Mannheim, a small family business in Germany, established itself as a supplier of quinine to combat malaria.

Corporate Social Responsibility

Corporate Social Responsibility is embedded in our culture. We are committed to supporting the health and success of the communities that we operate in.